Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   HECT and RING finger families of E3 ubiquitin ligases at a glance
  2. Metzger, M. B.; Hristova, V. A.; Weissman, A. M.
  3. Journal of Cell Science. 2012, Feb; 125(3): 531-537.
  1. 2.   A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma
  2. Keng, V. W.; Villanueva, A.; Chiang, D. Y.; Dupuy, A. J.; Ryan, B. J.; Matise, I.; Silverstein, K.; Sarver, A.; Starr, T. K.; Akagi, K.; Tessarollo, L.; Collier, L. S.; Powers, S.; Lowe, S. W.; Jenkins, N. A.; Copeland, N. G.; Llovet, J. M.
  3. Nature Biotechnology. 2009 27(3): 264-274.
  1. 3.   Targeting of gp78 for ubiquitin-mediated proteasomal degradation by Hrd1: Cross-talk between E3s in the endoplasmic reticulum
  2. Shmueli, A.; Tsai, Y. C.; Yang, M.; Braun, M. A.; Weissman, A. M.
  3. Biochemical and Biophysical Research Communications. 2009 390(3): 758-762.
  1. 4.   Id2 intrinsically regulates lymphoid and erythroid development via interaction with different target proteins
  2. Ji, M.; Li, H. J.; Suh, H. C.; Klarmann, K. D.; Yokota, Y.; Keller, J. R.
  3. Blood. 2008 112(4): 1068-1077.
  1. 5.   Effective therapy of murine models of human leukemia and lymphoma with radiolabeled anti-CD30 antibody, HeFi-1
  2. Zhang, M. L.; Yao, Z. S.; Patel, H.; Garmestani, K.; Zhang, Z.; Talanov, V. S.; Plascjak, P. S.; Goldman, C. K.; Janik, J. E.; Brechbiel, M. W.; Waldmann, T. A.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2007, May; 104(20): 8444-8448.
  1. 6.   Natural products active in aberrant c-Kit signaling
  2. Henrich, C. J.; Goncharova, E. I.; Wilson, J. A.; Gardella, R. S.; Johnson, T. R.; McMahon, J. B.; Takada, K.; Bokesch, H. R.; Gustafson, K. R.
  3. Chemical Biology & Drug Design. 2007, May; 69(5): 321-330.
  1. 7.   Novel lymphotoxin alpha (LT alpha) knockout mice with unperturbed tumor necrosis factor expression: Reassessing LT alpha biological functions
  2. Liepinsh, D. J.; Grivennikov, S. I.; Klarmann, K. D.; Lagarkova, M. A.; Drutskaya, M. S.; Lockett, S. J.; Tessarollo, L.; McAuliffe, M.; Keller, J. R.; Kuprash, D. V.; Nedospasov, S. A.
  3. Molecular and Cellular Biology. 2006, Jun; 26(11): 4214-4225.
  1. 8.   Oncogenic met receptor induces cell-cycle progression in Xenopus oocytes independent of direct Grb2 and shc binding or Mos synthesis, but requires phosphatidylinositol 3-kinase and Raf signaling
  2. Mood, K.; Saucier, C.; Ishimura, A.; Bong, Y. S.; Lee, H. S.; Park, M.; Daar, I. O.
  3. Journal of Cellular Physiology. 2006, APR; 207(1): 271-285.
  1. 9.   The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain,, RING finger, and an E2-binding site
  2. Chen, B.; Mariano, J.; Tsai, Y. C.; Chan, A. H.; Cohen, M.; Weissman, A. M.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 10; 103(2): 341-346.
  1. 10.   Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms
  2. Grivennikov, S. I.; Kuprash, D. V.; Liu, Z. G.; Nedospasov, S. A.
  3. International Review of Cytology - a Survey of Cell Biology, Vol 252. 2006; 252 : 129-+.
  1. 11.   FGFR1 function at the earliest stages of mouse limb development plays an indispensable role in subsequent autopod morphogenesis
  2. Li, C. L.; Xu, X. L.; Nelson, D. K.; Williams, T.; Kuehn, M. R.; Deng, C. X.
  3. Development. 2005, NOV; 132(21): 4755-4764.
  1. 12.   Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice
  2. Drutskaya, M. S.; Ortiz, M.; Liepinsh, D. J.; Kuprash, D. V.; Nedospasov, S. A.; Keller, J. R.
  3. Experimental Hematology. 2005, NOV; 33(11): 1348-1356.
  1. 13.   Conditional inactivation of Fgfr1 in mouse defines its role in limb bud establishment, outgrowth and digit patterning
  2. Verheyden, J. M.; Lewandoski, M.; Deng, C. X.; Harfe, B. D.; Sun, X.
  3. Development. 2005, OCT; 132(19): 4235-4245.
  1. 14.   ATP-regulated module (ARM) of the atrial natriuretic factor receptor guanylate cyclase
  2. Duda, T.; Venkataraman, V.; Ravichandran, S.; Sharma, R. K.
  3. Peptides. 2005, JUN; 26(6): 969-984.
  1. 15.   Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1
  2. Tao, Y. G.; Xing, S.; Deng, X. Y.; Xie, D. X.; Lee, L. M.; Liu, Y. P.; Wei, L.; Li, L. L.; Lin, D.; Qiao, W.; Gong, J. P.; Ya, C.
  3. Experimental Cell Research. 2005, FEB 15; 303(2): 240-251.
  1. 16.   Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter
  2. Sugaya, M.; Watanabe, T.; Yang, A.; Starost, M. F.; Kobayashi, H.; Atkins, A. M.; Borris, D. L.; Hanan, E. A.; Schimel, D.; Bryant, M. A.; Roberts, N.; Skobe, M.; Staskus, K. A.; Kaldis, P.; Blauvelt, A.
  3. Blood. 2005 105(6): 2356-2363.
  1. 17.   C/EBP alpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo
  2. Heath, V.; Suh, H. C.; Holman, M.; Renn, K.; Gooya, J. M.; Parkin, S.; Klarmann, K. D.; Ortiz, M.; Johnson, P.; Keller, J.
  3. Blood. 2004, SEP 15; 104(6): 1639-1647.
  1. 18.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 19.   Tyr-298 in ephrinB1 is critical for an interaction with the Grb4 adaptor protein
  2. Bong, Y. S.; Park, Y. H.; Lee, H. S.; Mood, K.; Ishimura, A.; Daar, I. O.
  3. Biochemical Journal. 2004 377(Part 2): 499-507.
  1. 20.   Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation
  2. Lin, Y.; Choksi, S.; Shen, H. M.; Yang, Q. F.; Hur, G. M.; Kim, Y. S.; Tran, J. H.; Nedospasov, S. A.; Liu, Z. G.
  3. Journal of Biological Chemistry. 2004 279(11): 10822-10828.
  1. 21.   Inositol 1,4,5-trisphosphate receptor ubiquitination is mediated by mammalian Ubc7, a component of the endoplasmic reticulum-associated degradation pathway, and is inhibited by chelation of intracellular Zn2+
  2. Webster, J. M.; Tiwari, S.; Weissman, A. M.; Wojcikiewicz, R. J. H.
  3. Journal of Biological Chemistry. 2003 278(40): 38238-38246.
  1. 22.   Mother nature's combinatorial libraries; their influence on the synthesis of drugs
  2. Kingston, D. G. I.; Newman, D. J.
  3. Current Opinion in Drug Discovery & Development. 2002 5(2): 304-316.
  1. 23.   Hepatocyte growth factor-stimulated invasiveness of monocytes
  2. Beilmann, M.; Vande Woude, G. F.; Dienes, H. P.; Schirmacher, P.
  3. Blood. 2000 95(12): 3964-3969.
  1. 24.   Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells
  2. Firon, M.; Shaharabany, M.; Altstock, R. T.; Horev, J.; Abramovici, A.; Resau, J. H.; Vande Woude, G. F.,; Tsarfaty, I.
  3. Oncogene. 2000 19(20): 2386-2397.
  1. 25.   A src-related kinase in the brush border membranes of gastrointestinal cells is regulated by c-met
  2. Sunitha, I.; Shen, R. L.; McKillop, I. H.; Lee, J. H.; Resau, J.; Avigan, M.
  3. Experimental Cell Research. 1999 250(1): 86-98.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel